Clinical Trial Update: Bone Marrow Transplantation Using CD34-Selected Stem Cells From Related or Unrelated Donors in Treating Participants With Cancer or Other Disorders

View source ↗

Summary

A clinical trial is studying CD34-selected stem cell transplantation from related or unrelated donors in participants with cancer or other disorders; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Neoplasm
• Malignant Neoplasm

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Benign Neoplasm, Bone Marrow Transplantation Recipient | Status: AVAILABLE